Hengxin Shambala Culture Co.,Ltd. (300081.SZ)
CNY 8.52
(-0.35%)
CNY 8.52
(-0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -83.99 Million | 29.57 Million | -8.14 Million | -35.49 Million | -128.6 Million | 4.01 Million |
| Net Income | -308.1 Million | -495.24 Million | -518.25 Million | -523.4 Million | 54.2 Million | 195.3 Million |
| Depreciation & Amortization | 86.12 Million | 66.5 Million | 74.66 Million | 43.56 Million | 30.35 Million | 23.32 Million |
| Deferred income taxes | 2.73 Million | -6.34 Million | -3.5 Million | -16.5 Million | 19.86 Million | -135.75 Thousand |
| Stock-based compensation | 3.35 Million | - | - | - | - | - |
| Change in working capital | -44.91 Million | 31.91 Million | -50.78 Million | 26.45 Million | -218.88 Million | -179.45 Million |
| Other non-cash items | 55.85 Million | 426.39 Million | 486.23 Million | 417.89 Million | 5.71 Million | -35.16 Million |
| Investing Cash Flow | -225.29 Million | -125.22 Million | 35.39 Million | -54.84 Million | -322.88 Million | -794.85 Million |
| Investments in PPE | -174.37 Million | -133.85 Million | -84.9 Million | -130.95 Million | -210.98 Million | -109.88 Million |
| Acquisitions | 500 Thousand | 19.26 Thousand | 26.85 Thousand | 27.08 Million | -15.09 Million | -247.01 Million |
| Investment purchases | -74.2 Million | -153.75 Million | -127.1 Million | -20.1 Million | -199.46 Million | -1.38 Billion |
| Sales/Maturities of investments | 23.62 Million | 162.04 Million | 247.38 Million | 69.06 Million | 102.93 Million | 950.7 Million |
| Other Investing Activities | -851.34 Thousand | 321.72 Thousand | 0.07 | 60.67 Thousand | -279.55 Thousand | -3.09 Million |
| Financing Cash Flow | -18.97 Million | -118.33 Million | 503.37 Million | 31.09 Million | -4.99 Million | 166.06 Million |
| Debt repayment | -5.56 Million | -313.2 Million | -588.6 Million | -345.8 Million | -667.35 Million | -30 Million |
| Dividends payments | -5.96 Million | -7.51 Million | -14.14 Million | -16.03 Million | -11.59 Million | -32.11 Million |
| Common Stock Repurchased | - | - | - | -27.68 Million | -24.19 Million | -6.74 Million |
| Common Stock Issuance | - | - | - | 27.68 Million | -116.5 Thousand | - |
| Other Financing Activities | -7.43 Million | 202.38 Million | 1.1 Billion | 392.92 Million | 703.8 Million | 228.17 Million |
| Accounts receivables | -47.04 Million | -38.49 Million | 4.62 Million | 137.1 Million | -151.02 Million | -114.78 Million |
| Accounts payables | 123.8 Million | 127.13 Million | -40.61 Million | -28.04 Million | 116.42 Million | 92.77 Million |
| Inventory | -124.41 Million | -50.37 Million | -11.29 Million | -66.09 Million | -204.14 Million | -157.31 Million |
| Other working capital | 126.53 Million | -6.34 Million | -3.5 Million | -16.5 Million | 19.86 Million | -22.14 Million |
| Cash at beginning of period | 387.01 Million | 600.86 Million | 70.4 Million | 130.57 Million | 585.94 Million | 1.21 Billion |
| Cash at end of period | 58.71 Million | 387.01 Million | 600.86 Million | 70.4 Million | 130.57 Million | 585.94 Million |
| Capital Expenditure | -174.37 Million | -133.85 Million | -84.9 Million | -130.95 Million | -210.98 Million | -109.88 Million |
| Effect of forex changes on cash | -33.17 Thousand | 124.45 Thousand | -164.82 Thousand | -936.12 Thousand | 1.11 Million | -435.81 Thousand |
| Net cash flow / Change in cash | -328.3 Million | -213.84 Million | 530.46 Million | -60.16 Million | -455.37 Million | -625.21 Million |
| Free Cash Flow | -258.37 Million | -104.27 Million | -93.05 Million | -166.44 Million | -339.58 Million | -105.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -64.46 Million | -47.74 Million | -30.74 Million | -308.1 Million | -180.95 Million | -34.65 Million |
| Depreciation & Amortization | - | 32.13 Million | 32.13 Million | 86.12 Million | 86.12 Million | -27.87 Million |
| Deferred income taxes | - | - | - | 2.73 Million | - | - |
| Stock-based compensation | - | 5.48 Million | - | 3.35 Million | 3.35 Million | - |
| Change in working capital | - | -51.04 Million | - | -44.91 Million | -171.45 Million | -14.38 Million |
| Other non-cash items | 132.74 Million | 46.51 Million | 17.58 Million | 55.85 Million | 260.71 Million | 60.95 Million |
| Investing Cash Flow | -6.08 Million | 29.27 Million | 40.31 Million | -225.29 Million | -108.66 Million | -60.41 Million |
| Investments in PPE | -10.23 Million | -11.07 Million | -9.49 Million | -174.37 Million | -34.92 Million | -61.07 Million |
| Acquisitions | - | - | 2000.00 | 500 Thousand | -342.44 Thousand | - |
| Investment purchases | -49 Million | - | -1 Million | -74.2 Million | -20 Million | - |
| Sales/Maturities of investments | 53 Million | 40.19 Million | 50.65 Million | 23.62 Million | -53.86 Million | 1.42 Million |
| Other Investing Activities | 150 Thousand | 150.79 Thousand | 149.2 Thousand | -851.34 Thousand | -380 Thousand | -761.34 Thousand |
| Financing Cash Flow | -12.92 Million | 8.05 Million | -6.42 Million | -18.97 Million | 17.11 Million | -2.44 Million |
| Debt repayment | -11.73 Million | -9.41 Million | -4.98 Million | -5.56 Million | -19.62 Million | -85.68 Million |
| Dividends payments | -1.19 Million | -1.24 Million | -1.19 Million | -5.96 Million | -1.46 Million | -1.03 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -113.86 Thousand | -238.68 Thousand | -7.43 Million | -1.04 Million | 84.27 Million |
| Accounts receivables | - | 11.28 Million | - | -47.04 Million | -47.04 Million | 52.97 Million |
| Accounts payables | - | - | - | 123.8 Million | - | - |
| Inventory | - | -62.33 Million | - | -124.41 Million | -124.41 Million | -67.35 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 83.22 Million | 79.45 Million | 58.71 Million | 387.01 Million | 155.85 Million | 234.66 Million |
| Cash at end of period | 85.68 Million | 83.22 Million | 79.45 Million | 58.71 Million | 58.71 Million | 155.85 Million |
| Capital Expenditure | -10.23 Million | -11.07 Million | -9.49 Million | -174.37 Million | -34.92 Million | -61.07 Million |
| Effect of forex changes on cash | -1889.54 | 794.34 | 140.88 | -33.17 Thousand | -20.55 Thousand | 13.32 Thousand |
| Net cash flow / Change in cash | 2.45 Million | 3.77 Million | 20.73 Million | -328.3 Million | -97.14 Million | -78.8 Million |
| Free Cash Flow | 58.04 Million | -44.43 Million | -22.64 Million | -258.37 Million | -40.49 Million | -77.03 Million |
SYNE3
000983
300845
IRVRF
WINT
PSYC